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Objectives: The aim of this study was to explore the variability in DNA quality and quantity along a gradient of
industrial processing of botanical ingredients from raw materials to extracts.
Methods: A data matrix was assembled for 1242 botanical ingredient samples along a gradient of industrial
processing commonly used in the Natural Health Product (NHP) industry. Multivariate statistics was used to
explore dependant variables for quality and quantity. The success of attaining a positive DNA test result along a
gradient of industrial processing was compared among four biotechnologies: DNA barcoding, NGS, Sanger
sequencing and qPCR.
Results: There was considerable variance in DNA quality and quantity among the samples, which could be
interpreted along a gradient from raw materials with greater quantities (50–120 ng/μL) of DNA and longer DNA
(400-500bp) sequences to extracts, which were characterized by lower quantities (0.1–10.0 ng/μL) and short
fragments (50-150bp).
Conclusions: Targeted molecular diagnostic tests for species identity can be used in the NHP industry for raw and
processed samples. Non-targeted tests or the use of NGS for any identity test needs considerable research and
development and must be validated before it can be used in commercial operations as these methods are subject
to considerable risk of false negative and positive results. Proper use of these tools can be used to ensure
ingredient authenticity, and to avert adulteration, and contamination with plants that are a health concern. Lastly
these tools can be used to prevent the exploitation of rare herbal species and the harvesting of native biodiversity
for commercial purposes.1. Introduction
Consumer conﬁdence in herbal medicine has been challenged by
reports of adulteration in the Natural Health Product (NHP) industry.
These reports are based on scientiﬁc studies of commercial NHPs in the
market place and have been published in peer-reviewed journals (Cheng
et al., 2015; Gao et al., 2017; Han et al., 2016; Newmaster et al., 2013;
Palhares et al., 2015; Raclariu et al., 2017; Shanmughanandhan et al.,
2016). Although these studies are founded on good science, the focus iny).
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is an open access article under tthe scientiﬁc literature and uptake in the public media has taken a critical
view of botanical industry; considerable adulteration was reported from
marketplace testing (De Boer, Ichim and Newmaster, 2015). This is un-
fortunate because there exists traditional and scientiﬁc knowledge,
including evidence-based health beneﬁts for many herbal medicines, that
offers the consumer an alternative to pharmaceuticals (Alvari et al.,
2012; Chikezie and Ojiako, 2015; Ernst, 2005; Izzo et al., 2016).
In order to gain consumer conﬁdence, the NHP industry must focus on
advancing the development of herbal medicine by addressing the2019
he CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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uncertainties in quality control of the supply of botanical ingredients that
could be addressed by science-based research and the development of
innovative solutions for quality assurance (De Boer et al., 2015; Woolfe
and Primrose, 2004). One of the key challenges in the NHP industry is
validating the identity of species ingredients. There is considerable sci-
entiﬁc evidence from published market place studies to suggest that the
current quality control methods using morphological, microscopy and
analytical chemistry are not sufﬁcient for conﬁrming the identity of many
botanical ingredients (Ananingsih et al., 2013; Chen et al., 2014; Scora,
1966). Morphological methods are often not possible on starting mate-
rials that lack the presence of taxonomic characters needed to identify
plant species. Microhistology based identiﬁcation using microscopy is
limited to a few species and the presence of anatomical characters, which
must be interpreted by highly skilled technicians. Analytical chemistry is
the most commonly used tool to validate botanical species ingredient
identity in the NHP industry. Testing protocols such as HPLC, MS and
TLC have been designed to identify chemical proﬁles and not necessarily
species ingredients. It is very difﬁcult to use analytical chemistry
methods on processed materials due the lack of standard reference ma-
terials for processed botanicals and the lack of research on impact of
processing on plant metabolites. The limited studies that exist suggest
that targeted metabolites in plants are altered during the processing of
NHPs, resulting in considerable variability in the test results or complete
failure of test methods (Ananingsih et al., 2013). Correlations between
metabolites and plant species are often assumed to be evidence for spe-
cies identiﬁcation, which is not an acceptable science-based approach
because the presence of a phytochemical does not infer phylogenetic
species concepts (Newmaster and Ragupathy, 2010; Urumarudappa
et al., 2016). DNA is inherent and reﬂects the evolutionary processes that
deﬁne species. This is not the case for plant chemicals of which most are
common to more than one species or may be highly variable within
species based on environmental mechanisms (Ananingsih et al., 2013). A
recent solution is DNA-based biotechnology, which has been suggested as
an additional tool for identity of botanical species ingredients in order to
ensure quality assurance and control in the supply chain of NHPs (De
Boer et al., 2015; Newmaster and Ragupathy, 2010; Orhan et al., 2016;
Raclariu et al., 2017; Sucher and Carles, 2008).
Although DNA-based tools offer potential solutions for testing raw
materials in the botanical supply chain, there are considerable research
gaps that need to be addressed in order to test processed botanical in-
gredients. DNA methods are well established as forensic tools for species
identity and as a standard diagnostic tool for probiotics and food borne
pathogens in commercial sectors (Davis, 2014; Harris and Grifﬁths, 1992;
Zhao et al., 2014). There are many tools to consider of which some are
appropriately validated, and others are not ﬁt for the purpose of species
ingredient authentication. Although DNA barcoding has been suggested
as a tool for authentication of botanical ingredients, this method is now
quite antiquated and is limited by several issues related the processing of
botanical ingredients; long sequence reads and limited to analysis of two
regions. Next Generation Sequencing (NGS) also has great promise in the
identiﬁcation of multiple non-targeted species ingredients within one
sample, but there are considerable issues that need to be addressed
before it can be used as a legitimate commercial tool. For example, the
lack of positive controls, inaccurate estimates of sequence reads (quan-
tiﬁcation may be biased and needs to be validated using dilution series
experiments, which are lacking), considerable PCR bias and bio-
informatic issues are causing a considerable number of false positives for
contaminants in both raw and in processed materials (Burns et al., 2016;
Coissac et al., 2012; Schrijver et al., 2012; Song et al., 2008). The key
uncertainty in these methods highlights the lack of knowledge on the
quantity and quality of DNA recovered from processed botanical in-
gredients. Raw materials have sufﬁcient DNA that is of good quality for
both DNA barcoding and in some cases NGS. This claim is supported by
several studies (Cheng et al., 2015; Gao et al., 2017; Han et al., 2016; Lu
et al., 2018; Newmaster et al., 2013; Palhares et al., 2015; Raclariu et al.,22017; Seethapathy et al., 2015; Shanmughanandhan et al., 2016) that
have demonstrated the ability to recover high quality DNA sequences
from raw materials. Some industry members have postulated that highly
processed NHPs may not have any DNA present. Recent research by Lu
et al. (2018) demonstrated the ability to visualize DNA in highly pro-
cessed botanicals using adapter-ligation and PCR ampliﬁcation methods.
Faller et al. (2019) further demonstrated the identity of target species
ingredients in highly processed extracts for green tea NHPs; he found
short DNA fragments of high quality DNA that is detectable for identi-
ﬁcation. However, this research is limited to only a few botanicals
leaving a gap in the breadth and depth of our knowledge of how me-
chanical processing such as grinding into powders or sanitization (e.g.,
steam treatment) affects the quality and quantity of DNA. This basic
understanding is required in order to formulate proper hypotheses and
statistical models required for assessing the probability of false neg-
atives/positives in commercial test assays. A suite of these tools needs to
be developed, optimized and tested in validation studies along a gradient
of industrial processing in order to assess the applicability of commer-
cialization of these tools and potential use in regulatory oversight.
The goal of this study is to explore the variability in DNA quality and
quantity along a gradient of industrial processing of a considerable
number of botanical ingredients from rawmaterials to botanical extracts.
This seeks to provide breadth and depth in botanical taxa within an
experimental model of increasing intensity of industrial processing. More
speciﬁcally we deployed multivariate statistics to explore dependant
variables for quality (fragment length ¼ number of base pairs) and
quantity (DNA content ng/μL) among 1242 botanical samples along a
gradient of industrial processing. These samples were also analyzed using
several DNA-based biotechnologies in order to assess the success of
attaining a positive DNA test results from raw botanical materials to
extracts. This exploratory research addressed the following questions 1)
What is the variability in DNA quality and quantity along a gradient of
industrial processing of botanical ingredients, and 2) how successful are
different DNA-based tools (DNA Barcoding, NGS, Mini-sequence,
Nucleotide Signature) in attaining positive identity results along a
gradient of NHP industrial processing from the farm to ﬁnished products
available to consumers.
2. Methods
A multivariate data matrix was assembled from 1242 botanical
samples representing 275 medicinal plant species. Two dependant vari-
ables, DNA quantity (ng/μL) and quality (fragment size in bp) were
assessed for each of the samples. Four independent variables represented
a gradient of industrial treatments including 1) Raw material from the
farm, 2) Powder (grinding of raw material), 3) Sanitization (steam
treatment), and 4) Extraction (extractive distillation, supercritical ﬂuid
extraction). Each of the four levels of treatment contained variability
among the class of treatment as deﬁned by each manufacture.
2.1. DNA quantity and quality
2.1.1. DNA extraction
DNA was extracted using the Macherey-Nagel NucleoSpin® Plant II
“Genomic DNA from Plant” Kit, from botanical materials (Macherey-
Nagel GmbH& Co. KG, Düren, Germany). Extractions of samples used 60
mg of dry starting material and were eluted in 60 μL of elution buffer.
Protocol was followed as according to the manufacturer's instructions.
2.1.2. DNA quantity (volume; ng/μL)
DNAwas quantiﬁed using a Qubit™ dsDNAHigh Sensitivity Assay Kit
on the Qubit™ 3.0 Fluorometer according to the manufacturer's in-
structions. All ng/μL concentration readouts from the ﬂuorometer were
based on NHP DNA extract samples eluted in 60 μL of elution buffer.
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Fragment size was estimated using an Agilent 2100 Bioanalyzer to
visualize size distribution in both smaller ranges of fragment sizes (spe-
ciﬁcally 25–1000 bp; using the DNA 1000 chip), as well as a larger
50–7000 bp range (using the High Sensitivity DNA chip) (Agilent Tech-
nologies, Santa Clara, CA). This estimate was further veriﬁed using a
4200 TapeStation instrument with a Genomic DNA ScreenTape (D1000)
and reagents (Agilent, Santa Clara, CA, USA).
2.2. Assessing DNA based tools
The relative test results from four different molecular diagnostic tools
were compared including the following: DNA Barcoding; Next Genera-
tion Sequencing; Mini-sequencing (Sanger sequencing); Nucleotide sig-
natures (DNA Probes and qPCR). Each of these tools were tested on NHPs
along a gradient of industrial treatments including: 1) raw material, 2)
grinding into powder, 3) sanitization (steam treatment), and 4) extrac-
tion (extractive distillation, supercritical ﬂuid extraction). The relative
success was compared among the technologies, with “success” deﬁned as
producing a quality DNA sequence. These were all predeﬁned tests
designed to match a targeted botanical species ingredient and were
named “positive test” if they matched the targeted botanical ingredient.
2.2.1. DNA barcoding
Two DNA regions (rbcL, and matK) were selected based on the rec-
ommendations by CBOL Plant Working Group (2009) as the ofﬁcial plant
barcoding markers. We isolated total genomic DNA from approximately
10 mg of dried leaf material from each sample using the NucleoSpin®
Plant II “Genomic DNA from Plant” kit (Macherey-Nagel GmbH & Co.
KG, Düren, Germany). Extracted DNA was stored in sterile micro-
centifuge tubes at –20 C. The selected loci were ampliﬁed by polymerase
chain reaction (PCR) on a PTC–100 thermocycler (Bio-Rad). DNA was
ampliﬁed in 20 μL reaction mixtures containing 1 U AmpliTaq Gold
Polymerase with GeneAmp 106 PCR buffer II (100 mm Tris-HCl pH 8.3,
500 mm KCl) and 2.5 mm MgCl2 (Applied Biosystems), 0.2mm dNTPs,
0.1mm of each primer (0.5mm for matK), and 20 ng template DNA.
Ampliﬁed products were sequenced in both directions with the primers
used for ampliﬁcation, following the protocols of the University of
Guelph Genomics facility (www.uoguelph.ca/~genomics). Products
from each specimen were cleaned using Sephadex columns and run on an
ABI 3730 sequencer (Applied Biosystems). Bidirectional sequence reads
were obtained for all the PCR products. Sequences were assembled using
Sequencher 4.5 (Gene Codes Corp), and aligned manually using Bioedit
version 7.0.9.
2.2.2. Next generation sequencing
Library preparation was performed at the Genotypic Technology's
Genomics facility. The PCR ampliﬁed product was checked on an agarose
gel before proceeding to PCR indexing. The PCR index reaction was
conducted using a Nextera® XT Index Kit v2 Set D kit from which Illu-
mina sequencing adapters and dual indexing barcodes were added using
limited cycle PCR (Initial Denaturation 95 C for 5min, Followed by 10
cycles of 98 C for 20s, 64 C for 15s, 72 C for 35s, a ﬁnal extension of 72
C for 5min). This provided a ﬁnal product of ~520bp and ~570bp. The
library was cleaned using HighPrep PCR magnetic beads (HighPrep PCR,
Magbio, Switzerland) and was Qubit quantiﬁed using Qubit ds DNA HS
kit (Invitrogen, USA). Qubit quantiﬁcation resulted in concentration of
1.91 ng/μl with total yield of 19.1 ng. The prepared library was then
validated for quality using High Sensitivity Bioanalyzer Kit (Agilent
Technologies, USA) by running an aliquot on High Sensitivity Bio-
analyzer Chip (Agilent Technologies, USA). The library was then pooled
for Illumina MiSeq sequencing using the 250bp paired end read
chemistry.
2.2.3. Mini-sequence analysis
Botanical species (275) as represented in the University of Guelph3NHP Research Alliance Standard Biological Reference Material (SBRM)
DNA library; Mini sequences were on average 100–120 bp and were
sequenced using a tiered approach (rbcL; ITS2) (Newmaster et al., 2006).
All triplicate samples of plant product (powder) from herbal products
were sequenced. Total genomic DNAwas isolated from 100 mg of the dry
voucher specimen and 60 mg of the herbal product using the Nucleo-
Spin_Plant II Mini DNA Extraction kit (Macherey-Nagel, Düren, Ger-
many). Additionally, an extraction control was used to monitor the DNA
extraction efﬁciency. The polymerase chain reaction (PCR) ampliﬁcation
was carried out using rbcL and ITS2 universal primers in a 10 l μl reaction
mixture that contained 0.001–20 ng of genomic DNA, 1.2 X of 10 X Pfu
buffer, 3 mM of MgSO4 (Fermentas, Waltham, Massachusetts, USA), 250
l M of 2 mM dNTPs (Fermentas), 0.2 l M each of forward and reverse
primers (10 l M), 0.5 U of 2.5 U Pfu DNA polymerase (Fermentas) and 0.5
% dimethyl sulfoxide (DMSO). A negative control was maintained for all
PCR reactions. The primers and the reaction conditions for rbcL and ITS2
were taken from Chen et al. (2010) and Fazekas et al. (2012). The PCR
products obtained were outsourced for DNA sequencing. The amplicons
were bi-directionally sequenced using ABI PRISM_377 sequencer
(Applied Biosystems, Foster City, CA, USA). The chromatographic traces
were aligned and codon read in the CodonCode Aligner version 3.0
(CodonCode, Centerville, MA, USA) and contigs were generated. Se-
quences were deposited into a local botanical reference material (RM)
library database.
2.2.4. Nucleotide signature qPCR
The sequences with high sequence similarity to each candidate
reference genes were aligned separately to highlight potential areas of
polymorphism. The primer pairs were designed by PrimerSelect of
Lasergene 8 (DNASTAR, Inc., Madison, WI, USA) following the recom-
mendations by Udvardi et al. (2008), and primer pairs were selected from
sequence region with the fewest polymorphisms. The ampliﬁcation
speciﬁcity of designed primers was conﬁrmed via standard qPCR pro-
cedures under different annealing temperature (50, 53, 56 and 59 C).
PCR ampliﬁcation efﬁciency was calculated using a two-fold serial
dilution of the cocktail of DNA templates. All PCR products were exam-
ined by melting curve analysis and agarose gel electrophoresis.
2.3. Multivariate analysis
The relationship of the classiﬁcation structure of the multivariate
matrix of DNA quality and quantity along a gradient of industrial pro-
cessing (details deﬁned above) was analyzed with nonmetric multidi-
mensional scaling (NMS) using the “R” software (Kruskal, 1964;
Maechler et al., 2013; Newmaster et al., 2008; R Core Team, 2014). In
NMS, the Bray-Curtis distance measure was used because of its robust-
ness for both large and small scales on the axes. Data were standardized
by variable maxima and two-dimensional solutions were appropriately
selected based on plotting a measure of ﬁt (“stress”) to the number of
dimensions. Stress represents distortion in the data, whereby a stress
value over 0.15 indicates that the results are invalidated. One thousand
iterations were used for each NMS run, using random start coordinates.
The ﬁrst 2 ordination axes were rotated to enhance interpretation with
the different axes. Differences in the membership of clusters were
analyzed using discriminant analysis and MRPP.
3. Results
3.1. DNA quantity and quality
There was considerable variation in the multivariate matrix of DNA
quality and quantity from 1242 samples. The NMS ordination (Fig. 1)
was constructed in a 2-dimensional structure with no additional variation
on the third axes; relative eigenvalues did not change after the second
axis (NMS axis 1 ¼ 2.46; NMS axis 2 ¼ 3.17; NMS axis 3 ¼ 3.24; NMS
stress value was 0.16). Variation in axes scores along NMS Axis one was
Fig. 2. Distribution of DNA Quantity for 1242 samples along a gradient of in-
dustrial processing from raw botanicals to extracts.
Fig. 3. DNA fragment size histogram for 1242 samples form a gradient of in-
dustrial processing from raw botanicals to extracts.
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the ordination resulted in several clusters of which sample results from
raw materials were grouped in the top left corner of the ordination and
those of extracts were on the bottom right hand corner. The sample re-
sults from ground samples (powder) and those subjected to
manufacturing processing were oriented between the left and right sides
of the ordination; sanitization tests overlapped with both powder sam-
ples and extracts. Two gradients were identiﬁed in the analysis including
1) DNA fragment size along axis 1 (Pearson Correlation 0.93; p < 0.01)
with longer fragments in raw materials and shorter in extracts, and 2)
DNA quantity along axis 2 in which more DNA was found in raw samples
(highest 120 ng/μL) and less (0.01 ng/μL) in extracts (Fig. 2).
The distribution of DNA quantity was heavily skewed toward small
amounts with increasing industrial processing (Fig. 2). Raw materials
contained large amounts (120 ng/μL) of DNA with lesser amounts asso-
ciated with speciﬁc species such as Aloe vera (1.8 ng/μl) or raw samples
from roots/rhizomes (e.g., Ginseng). Most raw botanicals had over 50.0
ng/μL. Industrial grinding botanical samples into powder reduced the
amount of DNA to <50.0 ng/μL. Sanitization such as steam treatment
further reduced DNA quantity to <20.0 ng/μL. The extract process still
resulted in the presence of DNA ranging from 0.1-10.0 ng/μL 3% of the
samples failed to produce any measurable DNA (Fig. 3).
DNA quality as deﬁned by fragment size is not evenly distributed
along a gradient of industrial treatments. Large fragments (400-500bp)
are associated with raw botanicals (Fig. 3). The ﬁrst step in processing,
which is grinding reduces fragment size followed by shorter fragments
after product sanitization. The extract process results in many small
fragments ranging from 50-150bp.
3.2. Assessing DNA based tools
There were considerable differences in the relative test results from
different molecular diagnostic biotechnology. Although DNA barcoding
was relatively successful on raw materials, it still failed to successfully
identify 25% of the samples. DNA barcode failure increases with more
intensive industrial processing with 90% failure in extracts. The results
from next generation sequencing (NGS) were marginally better with
considerable failure in extracts and the misidentiﬁcation of incidental
contaminant DNA as the dominant ingredient in ranging from 7% in raw
materials to 41% of the extracts that were successful sequenced. False
positives were validated by analytical chemistry. Mini-sequence methods
produced results for all the raw materials and ground powder samples
tested. The success of the mini-sequence method in extracts was twice
that of NGS and six times greater than DNA barcoding. Targeted PCR
methods using nucleotide signatures or DNA probes had the highest
success with positive results for 76% of extracts. We were able to get
positive results using targeted PCR in the samples that failed to produceFig. 1. NMS ordination of variation in DNA quantity and quality from 1242
samples along a gradient of industrial processing from raw botanicals
to extracts.
4any measurable DNA; this was not possible with the other three bio-
technologies. Comparison of six commercial kits produced positive re-
sults ranging from 12-34% of extracts.
4. Discussion
Increasing demand for NHPs creates more pressure on supply and in-
creases the probability of product adulteration and exploitation of native
biodiversity. A considerable proportion (60%) of the world's population
depends on traditional medicine, of which 80% of developing countries
depend almost entirely on traditional medicine practices and herbal
medicines as their primary health care (WHO, 2001). Rapid market
growth at 7% per year has resulted in a global market value that is ex-
pected to reach $86–100 billion USD by 2022 (CRN, 2017; ZMR, 2017).
Recent environmental concerns include the fact that some uncommon or
rare species of plants are being harvested for commercial use as NHPs
(Chen et al., 2016). There is immense pressure on the supply of botanical
ingredients, which may explain why there is adulteration and product
substitution levels of product ingredients (Cheng et al., 2015; Gao et al.,
2017; Han et al., 2016; Newmaster et al., 2013; Palhares et al., 2015;
Raclariu et al., 2017; Shanmughanandhan et al., 2016). TheWorld Health
Organization deemed the safety of NHPs a concern; with increasing use
and reports of adverse reactions, regulation standards need to be reviewed
to consider proper due diligence in quality assurance (WHO, 2004). There
is an immediate need for more adequate tools to authenticate botanical
supply chains for commercial use in the herbal industry.
Although analytical chemistry tools are already well-established tools
for quality control in the NHP industry, the addition of molecular diag-
nostic tools to quality control systems should be considered in order to
enhance efforts to mitigate adulteration. The discussions on whether to
use analytical chemistry or DNA based methods for quality assurance
should be based on a logical argument and relate to “ﬁt for purpose”
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protocols have been designed to identify chemicals and not necessarily
species ingredients. DNA is inherent and reﬂects the evolutionary pro-
cesses that deﬁne species; this is not the case for chemicals, of which
many are common to more than one species. We advocate the use of both
methods for optimal quality control programs including the use of 1)
chemical testing methods to validate the presence of chemical in-
gredients against validated standard reference materials, and 2) molec-
ular diagnostic DNA-based methods to identify species ingredients based
on validated methods with positive and negative controls. DNA methods
are well established as forensic tools for species identity and as a standard
diagnostic tool for probiotics and food borne pathogens (Davis, 2014;
Law et al., 2015; Zhao et al., 2014). Molecular diagnostic tools such as
species-speciﬁc nucleotide signatures using targeted methods on PCR
platforms can be validated for commercial use. This molecular diagnostic
biotechnology is poised to reinforce quality control systems against the
risk of fraudulent product substitution, adulteration, contamination, and
unlabelled ﬁllers.
Industry claims that DNA is completely destroyed or eliminated by
industrial processing, thus precluding DNA-based testing, are not sup-
ported by our research. Although we found a considerable gradient of
lower quantity of DNA represented by short sequences with intensive
industrial processing, we also demonstrated considerable success in
obtaining positive DNA identity test results from herbal extracts; some
industry stakeholders thought this was not possible. These results have a
logical explanation founded on mechanistic hypotheses. Herbal in-
gredients are exposed to various processing procedures including tech-
niques such as mechanical grinding, heat treatments, ultraviolent light
exposure, ﬁltration and ﬂuid extraction. The mechanistic physical impact
on the structure of the DNA following industrial processing is a plausible
explanation for lower quantity and shorter fragments of DNA. For
example, standard production protocols of NHPs typically include high
heat (>100 C) procedures for the purpose of drying, sanitization or
sterilization (Woolfe and Primrose, 2004). Previous research has
demonstrated that high temperatures such as those used in NHP pro-
cessing are sufﬁcient to break covalent bonds in dsDNA, and with pro-
longed exposure to temperatures above 100 C, completely degrade DNA
(Karni et al., 2013). Therefore, this would prohibit use of DNA based
diagnostic techniques due to absence of DNA template for ampliﬁcation
and sequencing. Additionally, UV light, which can be used in NHP pro-
cessing, is well known to be damaging to DNA via thymine dimer for-
mation; structurally compromised DNA may also be unable to be
effectively ampliﬁed or sequenced (Pehrson, 1989). Current research
(Faller et al., 2019) has demonstrated that processing of green tea leaves
during extract manufacturing results in shorter fragments of DNA (Faller
et al., 2019). DNA extraction methods that yield longer strands such as
precipitation methods (Malentacchi et al., 2016) may be used for optimal
results when working with unprocessed plant materials. However, we
have recently used new methods such as precipitation methods for bar-
coding and NGS, and do not see any improvement in the results. This is
because the processing of NHP samples during manufacturing breaks up
the DNA into small fragments; thus, there are no long fragments to
recover. These mechanisms are useful in interpreting our results. We
encourage further research based on experimental models that utilize
industrial processing treatments to test these hypotheses.
There was considerable variance in the relative success of molecular
diagnostic biotechnologies in testing NHP samples from a gradient of
industrial processing from raw botanicals to extracts. DNA barcoding had
the lowest success of all the molecular biotechnologies even when testing
raw materials. This is likely due to the to several factors including but
limited to the following 1) DNA barcoding by deﬁnition has limited
success with only a couple (rbcL andmatK) plastid regions (Fazekas et al.,
2010; Percy et al., 2014), 2) one of the regions (matK) is known to have
relatively low PCR success (Fazekas et al., 2008; Kress and Erickson,
2007; Newmaster et al., 2008), 3) both barcode regions are very long
(>500bp) and therefore not found in most of the processed samples5according to our research (Fazekas et al., 2012; Kress et al., 2005). We
suggest that DNA barcoding sensu stricto is not used for authentication of
botanical ingredients, as it will result in relatively low success in raw
materials and very low success in processed materials.
Although the non-targeted approach of NGS makes it an attractive
tool for potentially revealing any adulterant, NGS technology presents
several serious issues that prevent its current use as a commercial tool.
The lure of NGS is founded on the fact that it is an exciting research tool,
as it is very sensitive and can be used to detect multiple sources of DNA in
a single analysis. This makes NGS particularly useful for addressing
certain research questions focused on recreating dietary diversity
(Pompanon et al., 2012) or the study of traces of environmental DNA
(eDNA) in water and soils (Rees et al., 2014). However, the published
literature signiﬁes there are considerable limitations and problems with
NGS that present an immediate impediment to generating scientiﬁcally
valid test results for commercial use (Bianchi et al., 2016; Coissac et al.,
2012; Lighten et al., 2014; Waits and Paetkau, 2005). Notably, NGS re-
sults may indicate presence of species in a sample due only to detection of
small amounts of small fragmented contaminant DNA of which it may
over-estimate the number of sequences. We call these small DNA frag-
ments “incidental DNA fragments”. It is reasonable to postulate that all
food and NHP products have many small fragments of incidental DNA
from a number of different species, particularly agricultural species. In
fact, regulatory and pharmacopoeial botanical monographs speciﬁcally
allow small amount (2–5%) of foreign organic matter, and inadvertent
plant parts from co-mingled species in a harvested crop. Agricultural
harvesting systems are not sterile environments and small amounts of
DNA from surrounding vegetation will be present in all products. NGS
resulted in a considerable number of false positives in our study. We
suggest that this may be due to the fact that NGS is so sensitive it is
detecting incidental DNA in commercial products and through mecha-
nisms such as PCR bias overestimating the number of sequences resulting
in false positive for adulterants. This type of test result is a very big
problem for the industry, as they may have to reject a shipment, change a
supplier or recall a product line. The relatively low success of NGS in
processed products is due to the fact that the meta-barcoding NGS
pipeline needs considerable research and development. A NGS pipeline
standard operating protocol needs to be developed for a short DNA
sequence library. Based on our research we suggest 80–100 bp. It would
be difﬁcult to go shorter than 80 bp because there needs to be space for
primer design, and enough space to capture sequence variability to
differentiate all the target and non-target species. This is a challenge
considering there are over 1000 commoditized target botanical species
and an undetermined number of adulterants and possible contaminants.
This brings in a second very large issue with respect to variability in PCR
bias among plant species (Morgante and Olivieri, 1993). Corrective al-
gorithms for PCR bias can be created (Coissac et al., 2012; Reinecke et al.,
2015) but need to be developed for a complete DNA sequence library. If
one species is left out of the corrective bioinformatic model, then the
results are dubious. These issues can be used to explain why NGS was
relatively unsuccessful in our study and is not useful as a commercial test
at this time. In fact, during the last year our research institute has
reviewed over 100 commercial NGS tests from NHP products of which
the results did not make any sense to the NHP industry member; further
forensic investigation revealed that in every case there was either a false
negative, false positive or in many instances both. Limits of detection
(LOD) and quantiﬁcation (LOQ) must be developed and validated to
ensure that incidental DNA fragments present in every sample are below
some threshold. This would allow an acceptable low level of contaminant
DNA sequences in a quality assurance system and prevent false positives
for adulterants that could incorrectly trigger a costly non-conformity
process in a manufacturing facility. We suggest further research is
needed to resolve these issues before NGS can be implemented as a tool in
the quality control and identity of NHPs. A targeted molecular diagnostic
tool should be properly validated (Newmaster et al., 2018) method
including LOD/LOQ with deﬁned acceptable thresholds for small
S. Ragupathy et al. Heliyon 5 (2019) e01935amounts of incidental DNA sequences commonly found in every
substrate.
There are two approaches to developing a DNA-based assay for
testing species identity of botanical ingredients. A targeted assay or
deﬁned test in which the test is designed to identify one species in a
product at a time; multiple assays/tests can be utilized on one sample to
conﬁrm the identity of a mixture of species. A non-targeted test seeks to
list all the species in a product including the main species ingredient,
mixtures of species, adulterants, and contaminants. Although this test is
highly desirable, it is only theoretically possible and has only been
demonstrated within a controlled research projects in a lab. Currently it
is not possible to design a non-targeted assay as it would need to be
validated on a NGS platform, which is not possible for reasons previously
discussed in this manuscript. It is also a considerable challenge to develop
a reliable statistical model for a non-targeted assay for the NHP industry
because there are over a 1000 species that need to be in the model.
Currently we have a basic RM DNA library for the top 250 species; only
25% of the work has been completed for a foundational DNA library for
the NGS SOP pipeline and bioinformatic model. We are working on the
challenge of assembling such a library, NGS pipeline and statistical
model, with an estimated completion in 3–5 years. Targeted tests have
been validated (Newmaster et al., 2018) are available now and can be
deployed on sanger sequencing, qPCR/ddPCR, or targeted NGS once the
critical issue inherent to this method have been resolved. Targets can
include the botanical ingredients, and known adulterants including
closely related species and contaminants. We have developed this
approach using a short sequence botanical RM DNA library using sanger
sequencing and nucleotide signature qPCR, which was used in our study.
The results indicate there is considerably more success using this
approach rather than the non-targeted NGS approach. It is important to
note that we were able to get positive results using targeted PCR in the
samples that failed to produce any measurable DNA; this was not possible
with the other three biotechnologies. We did not use a targeted NGS
approach as it is not fully developed and suffers from the same issues
deﬁned in the previous paragraph. The NHP sector can learn from the
food ingredient, food borne pathogen and probiotic sectors in which they
have utilized targeted tests mainly on qPCR platforms. These industries
have avoided non-targeted tests and they have not embraced NGS tech-
nology as a commercial tool for quality control (Davis, 2014; Law et al.,
2015; Zhao et al., 2014; Newmaster et al., 2019).
We encourage researchers and industry stakeholders to collaborate in
the assemblage of botanical reference materials (RM) and validated
molecular diagnostic tools. The NHP Research Alliance is providing co-
ordination as it is focused on working with industry leaders and other
researchers to build and curate a comprehensive, vouchered RM library
for botanical ingredients in the food and NHP industry based on genome
scans and NMR analytical chemistry models for over 1000 plant species
with widespread population sampling. This will be used to develop more
advanced molecular diagnostic tools (e.g., micro arrays, microﬂuidic
devices, oxford nanopore etc.) focused on species-speciﬁc nucleotide
signatures for botanical ingredients and adulterants. It will be developed
in two phases of which phase one is a targeted approach that follows
intensive validation methods (Newmaster et al., 2018) that can be
deployed identity tools for qualifying supply chains and as a targeted
screening tool for adulterants. Phase two is non-targeted in research and
development that builds on the validated assays and RM libraries. We
feel that these tools will serve the botanical ingredient industry in mul-
tiple sectors (NHPs, food, beverage, alcohol, spices etc.) with reinforced
quality control systems that will protect companies against the risk of
fraudulent product substitution, adulteration, contamination, and unla-
belled ﬁllers.6Declarations
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